课题基金 / 基金详情

Development of histamine H_3 receptor selective ligands based on the versatile chiral cyclopropane units.

Development of histamine H_3 receptor selective ligands based on the versatile chiral cyclopropane units.
基于多功能手性环丙烷单元开发组胺 H_3 受体选择性配体。
批准号:
15590096
负责人:
SHUTO Satoshi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

SHUTO Satoshi的其他基金

相似基金

相关文献

中文摘要
翻译
高选择性的H_3受体激动剂和拮抗剂不仅是药理学研究的重要工具,而且是新药开发的重要先导。我们设计了一系列基于环丙烷的构象受限的组胺类似物,这些类似物是由我们以前开发的手性环丙烷单元有效地合成的。在这些受构象限制的类似物中,具有顺式环丙烷结构的(1 S,2S)-2-(2-氨乙基)-1-(1H-咪唑-4-基)环丙烷被鉴定为高度H_3选择性激动剂。在此基础上,设计了环丙烷类H_3选择性拮抗剂。这些化合物是通过在已发现的H_3选择性激动剂的结构中引入芳环而设计的,因为在激动剂的适当位置引入芳环有时会使其转化为相应的拮抗剂,这被认为是“伞形效应”。利用这些手性环丙烷单元合成了该类化合物,并发现了一些很强的H_3受体选择性拮抗剂,因此,我们利用这些多功能的手性环丙烷单元,在理论设计的基础上,成功地开发了H_3受体选择性激动剂和拮抗剂。
英文摘要
Highly selective H_3 agonists and also antagonists would not only be very useful as tools for pharmacological studies but would also be important as leads for the development of new drugs. We designed a series of cyclopropane-based conformationally restricted analogues of histamine, which were effectively synthesized from chiral cyclopropane units previously developed by us. Among these conformationally restricted analogues, (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane having the cis-cyclopropane structure was identified as a highly H_3-selective agonist. On the basis of these findings, cyclopropane-based H_3 selective antagonists were designed. These were designed by introducing an aromatic ring into the structure of the H_3 selective agonists found, since introduction of aromatic rings into the proper site of an agonist sometimes convert it into the corresponding antagonist, which has been recognized as "umbrella effect". These compounds were also synthesized from above chiral cyclopropane units, and some very strong H_3 receptor antagonists with selectivity were found. Thus, we successfully developed H_3 selective agonists and antagonists based on theoretical design using the versatile chiral cyclopropane units.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2004
期刊: J.Org.Chem. 69
影响因子: --
作者: [Y.Kazuta, et al.]
通讯作者: et al.
DOI: --
发表时间: 2004
期刊: J.Org.Chem. 69
影响因子: --
作者: [Y.Kazuta, et al.]
通讯作者: et al.
Synthesis of 4,8-anhydro-D-glycero-D-ido-nonanitol 1,6,7-trisphosphate as a novel IP_3 receptor ligand using a stereoselective radical cyclization reaction based on a conformational restriction strategy.
使用基于构象限制策略的立体选择性自由基环化反应合成 4,8-脱水-D-甘油-D-异-壬醇 1,6,7-三磷酸作为新型 IP_3 受体配体。
DOI: --
发表时间:
期刊: Tetrahedron (in press)
影响因子: --
作者: [M.Terauchi, et al.]
通讯作者: et al.
オングストロムの分子設計 ナノバイオエンジニアリング,化学フロンティア(杉本直己編)
Angstrom分子设计纳米生物工程、化学前沿(杉本直树主编)
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [Koizumi, N., Mizuguchi, H., Sakurai, F, Yamaguchi, T., Watanabe, Y., Hayakawa, T., Kazuhiro Haraguchi, 周東 智]
通讯作者: 周東 智
16
    A Versatile Strategy for Developing Long-Acting Ligands by Ligand-Phospholipid Conjugation
    • 批准号:
      16K15136
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2016
    • 负责人:
      SHUTO Satoshi
    • 依托单位:
    Medicinal chemical study by the three-dimensional structural diversity-oriented strategy based on the characteristic steric and stereoelectronic features of cyclopropane
    • 批准号:
      24390023
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.23万
    • 财政年份:
      2012
    • 负责人:
      SHUTO Satoshi
    • 依托单位:
    Investigation of the mechanism of insulin secretion via Ca
    • 批准号:
      23659049
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      SHUTO Satoshi
    • 依托单位:
    Useful β-turn mimetics having three-dimensional diversity
    • 批准号:
      21390028
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2009
    • 负责人:
      SHUTO Satoshi
    • 依托单位:
    国内基金
    海外基金
    促性腺激素释放激素II型(GnRH-II)的激动剂和拮抗剂在子宫内膜癌中作用分子机制研究
    • 批准号:
      81101952
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2011
    • 负责人:
      赵丽君
    • 依托单位:
    新型M4受体选择性拮抗剂的研究